Non-Hodgkin's lymphoma presenting as thyroid enlargement

Area of Science:

• Oncology
• Radiation Oncology
• Hematology

Background:

• Non-Hodgkin's lymphoma can present as thyroid enlargement.
• Limited data exists on the optimal treatment for thyroid non-Hodgkin's lymphoma.
• Thyroid lymphoma is a rare malignancy requiring specific treatment strategies.

Purpose of the Study:

• To evaluate the efficacy of radiation therapy for non-Hodgkin's lymphoma of the thyroid.
• To determine optimal treatment strategies based on disease stage.
• To analyze survival and relapse rates in patients treated for thyroid lymphoma.

Main Methods:

• Retrospective analysis of 11 patients with thyroid non-Hodgkin's lymphoma treated between 1969-1978.
• Staging included lymphangiogram and bone marrow biopsy.
• Treatment modalities included irradiation and chemotherapy, with a focus on high-dose regional irradiation for early stages.

Main Results:

• Eight patients with Stage I-II disease treated with irradiation showed an 83.3% three-year survival and 75% two-year relapse-free survival.
• No local recurrence was observed in Stage I-II patients treated with irradiation.
• Three patients with Stage III-IV disease experienced poor outcomes, with two relapsing within one year and the third relapsing after nine years.

Conclusions:

• High-dose regional irradiation is the recommended treatment for Stage I-II non-Hodgkin's lymphoma of the thyroid.
• Advanced stage disease (III-IV) has a poorer prognosis despite aggressive treatment.
• Radiation therapy offers a high chance of survival and disease control for early-stage thyroid lymphoma.